Anthony Whitton
Papers
2
Total Citations
60
H-Index
2
About
Anthony Whitton is a leading clinical researcher in neuro-oncology, specializing in the treatment of glioblastoma multiforme and brain metastases through advanced radiosurgical techniques. His most impactful work addresses the critical challenge of locally recurrent glioblastoma, where treatment options are severely limited. In his landmark 2014 prospective cohort study, Whitton demonstrated that fractionated stereotactic radiosurgery combined with temozolomide chemotherapy achieves a significant response rate with acceptable toxicity for these patients—a finding that has garnered 56 citations and influenced salvage therapy protocols. Beyond clinical outcomes, Whitton brings a health economics perspective to radiosurgery. His 2013 study on robotic radiosurgery for brain metastases introduced a pragmatic cost-benefit analysis using willingness-to-pay metrics, helping healthcare decision-makers balance community need, cost, and patient preferences when allocating scarce radiosurgery resources. This dual focus—pushing the boundaries of treatment efficacy while rigorously evaluating economic sustainability—marks Whitton as a uniquely pragmatic voice in radiation oncology, bridging the gap between cutting-edge technology and real-world healthcare delivery.
Research Focus
Key Achievements
Top Papers
- 1
- 2